Breaking News
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Factors associated with increased risk of developing surgical site infections
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Study explores daily exposure to indoor air pollutants
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
February 21, 2019 - Overweight, obesity in adolescence associated with increased risk of renal cancer later in life
February 21, 2019 - BGU develops new AI platform for monitoring and predicting ALS progression
February 21, 2019 - Researchers discover a new promising target to improve HIV vaccines
February 21, 2019 - Brief Anesthesia in Infancy Does Not Mar Neurodevelopment
February 21, 2019 - Gaming system helps with autism diagnosis
February 21, 2019 - Heart Disease: Six Things Women Should Know
February 21, 2019 - More States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
February 21, 2019 - Researchers explore case studies focused on industries that kill more people than employed
February 21, 2019 - Only half of GP practice buildings are fit for purpose
February 21, 2019 - Intense exercise, fasting and hormones can enhance waste-protein removal, study shows
February 21, 2019 - Scientists can monitor brain activity to predict epileptic seizures few minutes in advance
February 21, 2019 - Study quantifies hepatic and intestinal mRNA expression of Ugt isoforms in rats
February 21, 2019 - ‘Apple-Shaped’ Body? ‘Pear-Shaped’? Your Genes May Tell
February 21, 2019 - Can we repair the brain? The promise of stem cell technologies for treating Parkinson’s disease
February 21, 2019 - Trump Plan To Beat HIV Hits Rough Road In Rural America
February 21, 2019 - PENTAX Medical introduces new electrosurgical and argon plasma coagulation platforms
February 21, 2019 - Trump plan to beat HIV hits rough road in rural America
February 21, 2019 - Eating blueberries every day could help decrease blood pressure
February 21, 2019 - ‘No Second Chances’ report calls for new measures to combat cardiovascular disease in Australia
February 21, 2019 - Mayo clinic researchers discuss local case studies of leprosy
February 21, 2019 - Scientists demonstrate key role of salt in allergic immune reactions
February 21, 2019 - Experts propose revising the criteria for diagnosis of Parkinson’s disease
February 21, 2019 - The med student and the machine
February 21, 2019 - Hey, Hey! Ho, Ho! Is Striking For School Nurses The Way To Go?
February 21, 2019 - Latest research encourages children to move out and learn through physical activity
February 21, 2019 - Proper oral hygiene and regular visits to dentist can promote heart health
Study finds false negatives in common tests used to determine ROS1 status in lung cancer

Study finds false negatives in common tests used to determine ROS1 status in lung cancer

image_pdfDownload PDFimage_print

Drugs like crizotinib are used to treat patients with ROS1-positive lung cancer. But which patients are ROS1-positive? A University of Colorado Cancer Center study published in the Journal of Thoracic Oncology shows that common laboratory tests used to determine ROS1 status all have inherent limitations that can lead to false-negative results. Some samples that were determined to be ROS1-negative by one test were shown to be ROS1-positive by another, meaning that some patients who could benefit from ROS1-directed therapy may be slipping through the cracks.

A commonly used test, based on a technique known as fluorescence in situ hybridization (FISH), provided a false negative for 2 of 20 samples known to be ROS1-positive; a test that sequences and analyzes ROS1 DNA was negative in 4 of 18 positive samples; and a test that looks for ROS1 fusion RNA was negative in 3 of 19 positive samples.

“The main point is just to be aware of the deficiencies in these assays and not to always trust a negative result from a single test. If you’re suspicious that a patient could be ROS1-positive – maybe they’re a never-smoker without other known drivers such as EGFR, ALK, KRAS, BRAF – then it may be useful to try another kind of test,” says Kurtis Davies, PhD, Lead Assay Development Scientist at the Colorado Molecular Correlates Laboratory (CMOCO).

Davies, the study’s first author, worked closely with colleagues including senior authors Robert C. Doebele, MD, PhD, director of the CU Cancer Center Thoracic Oncology Research Initiative, and Dara Aisner, MD, PhD, CMOCO Director in the CU Department of Pathology, which routinely employs multiple modes of testing cancer specimens.

“The University of Colorado has been a big player in the clinical research of ROS1 lung cancer, and so we have a lot more ROS1-positive samples than almost anywhere else. This allowed us to go back to our large bank of samples to test them in these three ways,” Davies says.

The study found that each test has inherent deficiencies. ROS1-positive cancers are caused by the gene ROS1 fusing with one of a number of partner genes. One of these possible partners sits very near to ROS1 on chromosome 6. When ROS1 fuses with this nearby partner, there may not be enough DNA deleted to identify the fusion using FISH.

“It can leave enough of the FISH probe binding sites that the sample appears normal even though a ROS1 fusion is present,” Davies says.

The deficiency in the DNA-based test was due to the inherent inability to properly sequence large areas of the ROS1 gene.

“You have large swaths of un-sequenced DNA and if the ROS1 change is in one of those areas, it’s possible to miss it,” Davies says.

“Some regions of DNA can be very challenging to sequence due to highly repetitive sequences, so simply trying to sequence those regions doesn’t necessarily fix the deficit,” Aisner says.

Unlike the other two tests, the assay based on RNA doesn’t attempt to take a snapshot of altered ROS1 DNA. Instead, it looks at what is manufactured from the DNA. This means that an RNA-based assay has the potential to more directly test for the results of ROS1 gene fusion that can drive cancer. That is, as long as you have good enough RNA.

“The deficiency in assays based on RNA is that they depend on RNA quality, which can be bad in clinical samples,” Davies says.

On the plus side, pathologists looking at the assay data can tell if RNA is of high enough quality to believe test results. (“We know when RNA quality is low,” Davies says.) In these cases, the FISH or DNA test could be used. And the false-negatives attributed to the RNA assay in this study were all due to low RNA quality.

“If you take out the negatives due to RNA quality (which we don’t really regard as negative), there were no false negatives with this kind of test,” Davies says.

Again, according to Davies, the takeaway is to realize there is no perfect test and sometimes secondary analysis with a different test is necessary to confirm results. The strategy is more than theory.

“We’ve run FISH concurrently with the RNA test for the past 18 months,” Davies says. “This helps us to provide every reassurance that we are not missing patients who can benefit from ROS1 directed therapy.”

The strategy of testing by two methods has paid off.

“One of the patients included in this study was initially determined to be ROS1-negative via FISH, but was subsequently shown to be ROS1-positive via RNA,” Aisner says. “This patient went on to receive ROS1 targeted therapy and demonstrated an impressive response.”

Tagged with:

About author

Related Articles